EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Loss of meningothelial identity and mesenchymal fate switching in NF2-mutant meningiomas

Ramin Rahmanzade, Leonille Schweizer, Simone Schmid, Tereza Lausová, Gianluca Sigismondo, Mozhgan Esmaeili Benvidi, Rushda Patel, Aras Fuat Kaan, Rouzbeh Banan, David Reuss, Natalie Jäger, Marie-Theresa Forster und 20 weitere

Acta Neuropathologica · 25.04.2026 · 151 (1)

DOI: 10.1007/s00401-026-03016-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Neuropathologica, online erschienen am 25.04.2026. Verfasst von Ramin Rahmanzade und 31 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuropathology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany. Hauptthemen laut MEDLINE: Meningioma, Meningeal Neoplasms, Sarcoma, Neurofibromin 2. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsklinikum Heidelberg.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Intracranial sarcomas can arise secondarily from primary brain tumors, including gliomas and meningiomas, either spontaneously or following radiotherapy. The current WHO classification recognizes sarcomatous transformation in several tumor entities; however, sarcomas arising from meningiomas remain poorly characterized and are regarded as a possible histological manifestation within the spectrum of anaplastic meningiomas. We analyzed nine matched meningioma–sarcoma pairs using integrated histopathological assessment and molecular profiling, including DNA methylation analysis, next-generation sequencing, copy number profiling, and proteomics. Although recurrent sarcomatous tumors were clonally related to their meningioma precursors—sharing identical NF2 alterations and overlapping chromosomal aberrations—they demonstrated pronounced divergence at the histological, immunophenotypic, and epigenetic levels. Importantly, sarcomatous transformation occurred in four cases without prior radiotherapy. Sarcomatous recurrences exhibited loss of meningothelial markers and acquired expression of cytokeratin and myogenic markers. DNA methylation profiling revealed a shift away from canonical meningioma signatures toward profiles resembling non-meningothelial mesenchymal tumors. Proteomic analysis showed consistent upregulation of SOX2 in sarcomatous tumors compared with their primary counterparts, suggesting acquisition of stem-like features during lineage divergence. Clinically, these tumors were associated with aggressive growth, early recurrence, and extracranial metastases, resembling malignant sarcomas more closely than anaplastic meningiomas. In addition, analysis of an institutional cohort of NF2-mutant intracranial tumors (n = 316) suggests that sarcomas with inactivating NF2 mutations may originate from meningiomas even in the absence of a clinically recognized precursor. Together, these findings suggest that sarcomatous transformation represents a rare evolutionary endpoint in NF2-mutant meningiomas, marked by clonal continuity but pronounced biological divergence. These results highlight limitations of morphology-based classification and emphasize the value of integrated molecular diagnostics in distinguishing these tumors from conventional high-grade meningiomas. Given their sarcoma-like behavior despite a meningioma ancestry, these tumors may not be adequately captured by current meningioma grading schemes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MeningiomaMeningeal NeoplasmsSarcomaNeurofibromin 2HumansFemaleMaleMiddle AgedMutationAdultDNA MethylationAgedCell Transformation, NeoplasticNeoplasm Recurrence, Local

Stichwörter der Autor:innen

Anaplastic meningiomaLineage plasticityNF2SOX2Sarcoma

Substanzen

NF2 protein, humanNeurofibromin 2

Autor:innen und Institutionen

  • Department of Neuropathology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
  • Clinical Cooperation Unit Neuropathology (B300), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 224, 69120, Heidelberg, Germany.
  • Institute of Pathology, Ludwig Maximilians University Hospital Munich, Munich, Germany.
  • Departments of Neuropathology, Edinger Institute, Institute of Neurology, University of Frankfurt Am Main, Heidelberg, Germany.
  • Frankfurt Cancer Institute (FCI), Frankfurt Am Main, Heidelberg, Germany.
  • German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Förderung

  • Universitätsklinikum Heidelberg

Zitieren

APA

Rahmanzade, R., Schweizer, L., Schmid, S., Lausová, T., Sigismondo, G., Esmaeili Benvidi, M., Patel, R., Kaan, A. F., Banan, R., Reuss, D., Jäger, N., Forster, M. T., Zeller, V., Kohlhof-Meinecke, P., Fisseler-Eckhoff, A., Carl, B., Harter, P. N., Lamszus, K., Schüller, U., …, & Sahm, F. (2026). Loss of meningothelial identity and mesenchymal fate switching in NF2-mutant meningiomas. Acta Neuropathologica, 151(1). https://doi.org/10.1007/s00401-026-03016-3

Vancouver

Rahmanzade R, Schweizer L, Schmid S, Lausová T, Sigismondo G, Esmaeili Benvidi M, et al. Loss of meningothelial identity and mesenchymal fate switching in NF2-mutant meningiomas. Acta Neuropathologica. 2026;151(1). doi:10.1007/s00401-026-03016-3

BibTeX
@article{Rahmanzade2026,
  author = {Rahmanzade, Ramin and Schweizer, Leonille and Schmid, Simone and Lausová, Tereza and Sigismondo, Gianluca and Esmaeili Benvidi, Mozhgan and Patel, Rushda and Kaan, Aras Fuat and Banan, Rouzbeh and Reuss, David and Jäger, Natalie and Forster, Marie-Theresa and Zeller, Viktoria and Kohlhof-Meinecke, Patricia and Fisseler-Eckhoff, Annette and Carl, Barbara and Harter, Patrick N and Lamszus, Katrin and Schüller, Ulrich and Zapotocky, Michal and Acker, Till and Hanemann, C O and Schittenhelm, Jens and Brack, Eva and Flucke, Uta and Mechtersheimer, Gunhild and Bertero, Luca and Haberler, Christine and Capper, David and von Deimling, Andreas and Sievers, Philipp and Sahm, Felix},
  title = {Loss of meningothelial identity and mesenchymal fate switching in NF2-mutant meningiomas},
  journal = {Acta Neuropathologica},
  year = {2026},
  volume = {151},
  number = {1},
  doi = {10.1007/s00401-026-03016-3}
}
Kostenlos starten →